Durham-based IQVIA to manage clinical trial of hydroxychloroquine vs. COVID-19 Date Published: May 22, 2020 Durham-based IQVIA has been selected to manage COVID SHIELD, an Australian clinical study of hydroxychloroquine, the drug President Trump said…
Durham medtech startup Validic receives kudos for virtual care technology Date Published: May 20, 2020 DURHAM – Durham medtech startup Validic has been named the winner of its “Best Hospital Technology Implementation” award as part…
NC IDEA picks six startups from across the state for $50,000 grants Date Published: May 14, 2020 DURHAM – NC IDEA today announced the selection of six NC IDEA SEED grant recipients, awarding a total of $300,000…
Durham’s Kriya Therapuetics lands $80M to advance gene therapies for diabetes, severe obesity Date Published: May 13, 2020 PALO ALTO, Calif. and DURHAM — Flush with cash, Kriya Therapeutics has big plans. The biotech startup, with headquarters in…
Durham firm designs a post-pandemic office with emphasis on social distancing Date Published: May 12, 2020 DURHAM – Office workspaces evolved from desks to cubicles to wide-open spaces with standing desks to … what in the…
Triangle drugmaker may have treatment for coronavirus – and another for smallpox Date Published: May 5, 2020 A Triangle drugmaker is beginning trials for a potential treatment for Covid-19 while at the same time the company is…
Durham startup targeting pancreatitis raises $2.7M from 19 investors Date Published: May 5, 2020 DURHAM – Lamassu Pharma, a biotech startup that is developing small molecule therapeutics to treat acute pancreatitis, has found plenty…
Durham pharma company to test its experimental cancer drug on COVID-19 patients Date Published: May 1, 2020 A Durham-based biopharmaceutical company says it has gotten the okay from the Food and Drug Administration to test its experimental…
Durham’s Chimerix gets FDA nod to test cancer drug in COVID-19 patients Date Published: April 30, 2020 DURHAM — Chimerix has gotten the green light to test an investigational cancer drug to treat COVID-19 patients. The Durham-based…